c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
about
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's DiseaseMLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2.Gαi3-Dependent Inhibition of JNK Activity on Intracellular Membranes.JNK at the crossroad of obesity, insulin resistance, and cell stress response.MALT1 promotes melanoma progression through JNK/c-Jun signalingLoss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.JNK Regulation of Depression and Anxiety
P2860
Q26770431-FFF9620E-ABD9-44D1-B7B3-4FCAAB2C2018Q35936981-86862D95-7B99-4267-87E2-0BEA742C2413Q36014957-31D8898D-9052-4AAB-9504-BDAE590D300CQ37613827-5A475754-3450-48A1-B3F1-CD3A5F31E0A6Q41228856-B79C0AAE-A629-4EEA-8E18-B0DB8AFBEF93Q44597957-1CE27F22-031A-4862-865A-1C44A0122028Q58790371-B9BB0264-7F55-4301-A036-BB3F9E21A558
P2860
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
@en
type
label
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
@en
prefLabel
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
@en
P2860
P1476
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
@en
P2093
Felix Muth
Pierre Koch
P2860
P304
P356
10.1517/13543776.2015.1039984
P407
P577
2015-05-19T00:00:00Z